spacer
home > pmps > summer 2002 > counterfeit drugs - a clear and present danger
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Counterfeit Drugs - A Clear and Present Danger

Drugs - An Easy Target

The tip of the iceberg is clearly visible and getting larger by the day. Drug counterfeiting and diversion are flourishing in today's world of tumbling international trade barriers, easy global marketing reach via the Internet, and simple access to sophisticated manufacturing and packaging technologies. Drug counterfeiting has steadily evolved from small-scale, opportunistic, activities in less regulated parts of the world to what has now become a widespread global threat to consumers and brand owners. Informed estimates put the size of the annual global market in fake drugs somewhere in the region of US$30 billion, representing about seven per cent of pharmaceutical industry revenue. Even more alarming are results of surveys showing that counterfeit drugs in some countries comprise in excess of 50 per cent of the market. These activities clearly put consumers at risk, threaten corporate and brand integrity, and generate significant cash for organised crime and terrorist groups.

Pharmaceuticals are an attractive target to counterfeiters, mainly because they have a high value in relation to their physical bulk. Consider some of the anti-cancer and anti-HIV treatments where a single pallet of product can represent many millions of dollars - for example, a standard 12-week course of Serostim treatment for HIV/AIDS patients costs approximately US$21,000.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr James Rittenburg, Vice President of Technology and Business Development at Biocode Dr James Rittenburg joined Biocode in 1994 and is currently Vice President of Technology and Business Development. He received his PhD in Microbiology from the University of Maine at Orono in 1981 and has over 20 years' experience developing immunodiagnostic systems for detecting trace levels of chemicals in samples including pharmaceuticals, foods, beverages, petrochemicals and agricultural products.
He has edited several books, authored numerous journal articles and is an inventor on a number of patents in this field. Prior to joining Biocode, James was Director of Product Development for Quantix Systems, where he had responsibility for overseeing the development of immunodiagnostic systems for detecting and measuring environmental pollutants.

spacer
Dr James Rittenburg
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Running Better Trials Taking an Intelligent Monitoring Approach

Bioclinica

When it comes to implementing a risk-based monitoring program, it is not just about reducing monitoring visits and doing less Source Document Verification (SDV). Itís about bringing together your people, a solid process, and the right technology to run a better trial. Success with risk-based monitoring requires the ability to make sense of the thousands, if not millions, of data points captured by multiple disparate sources in a clinical trial. With the sheer volume of data generated on a daily basis comes complexity. How does one make sense of it all? Information overload burdens even the most experienced study teams who struggle to understand which data matters most and what it means.
More info >>

 
Industry Events

CPhI & P-MEC India

26-28 November 2019, India Expo Centre, Greater Noida, Delhi NCR, India

As the pharma industry looks increasingly towards India for high quality, low cost pharma solutions, CPhI & P-MEC India is the ideal event for companies wanting to pick up on the latest trends and innovations the market has to offer. At CPhI & P-MEC India, you will meet the movers and shakers from India's pharma machinery, technology and ingredients industries, giving you a competitive advantage that will help grow your business.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement